comprehensive -WSS

comprehensive

author：leisure time 2025-10-02 22:27:42 - browse：4617

Have you ever taken phenylephrine for a stuffed-up nose and then felt better? If so, you might have been perplexed when Food and Drug Administration experts recently said that that the drug — which is in some versions of DayQuil, Sudafed, and other medicines — is no more effective than a placebo.

But to Michael H. Bernstein, an assistant professor of diagnostic imaging at the Warren Alpert Medical School of Brown University, it all makes sense. Bernstein says that “no better than a placebo” still means that it works, sort of. “If we expect to feel better, then we probably will,” he told me. And that complicates the idea of what medical treatment “works.”

On this episode of the “First Opinion Podcast,” we discuss the placebo effect and its counterpart, the “nocebo effect” — if you tell patients something will make them feel worse, it generally comes true. “You’re better off hearing from a doctor something to the effect of 3 out of 4 patients who take this drug have no side effects at all versus 25% of people who take this drug do get side effects,” he said.

Bernstein also shared the delightful story of how he got into the “medical expectations” field, which started with an experiment in which he had to convince underage students that they were drinking alcohol when they weren’t.

Our conversation was based on a First Opinion Bernstein recently wrote with Grayson L. Baird, “Phenylephrine is no better than a placebo. What if that’s still better than nothing?”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Coloradans with cystic fibrosis could lose access to Trikafta

hotspot

WSS

Travis Kelce and the trap of celebrity vaccine endorsements

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

Listen: Biogen's messy board & Laronde's data problem

Brain 'hot spot' may explain why African Americans feel greater pain

Listen: Biogen's messy board & Laronde's data problem

How to convince healthy people to buy insurance

Wikipedia

comprehensive

entertainment

Jerome Adams on the need for new antivirals for Covid

A new study asks: Are we harming blood donors by taking blood?

Wildfire smoke exposes gaps in outdoor worker protections

Humans aren't the only ones with an imagination. Rats have it too

Medical records are filled with copy

Brain 'hot spot' may explain why African Americans feel greater pain

Peter Hotez and the public health issue of online harassment

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

Tori Bowie and the unacceptable rates of Black maternal death

Grail is spending more than ever lobbying Congress

knowledge

Australia's humpback populations rebound raising hopes of marine scientists

Can food be medicine? And other questions about a new push

Connecting traumatic brain injury and domestic violence

These geoengineering technologies could help combat the climate crisis, scientists say

7 people shot in DC, police say

All of Us, NIH's precision medicine initiative, gets a big boost

hotspot

focus

focus

knowledge